Skip to main content
Clinical Trials/NCT06432998
NCT06432998
Completed
Not Applicable

Oncological Perineal Massage in Vaginal Stenosis and Dyspareunia in Women With Gynecological Cancer

University of Alcala2 sites in 1 country35 target enrollmentMay 31, 2024

Overview

Phase
Not Applicable
Intervention
Perineal massage
Conditions
Cancer Pain
Sponsor
University of Alcala
Enrollment
35
Locations
2
Primary Endpoint
Pain (Visual Analoge Scale)
Status
Completed
Last Updated
yesterday

Overview

Brief Summary

The high incidence of gynecological cancers, together with dyspareunia and vaginal stenosis, some of its most frequent sequelae, create the need to continue studying and researching oncological physiotherapy techniques that treat and prevent these sequelae, in order to preserve and/or improve the quality of life of cancer patients. Therefore, through this study, we sought to verify the effectiveness of oncological perineal massage to treat pain during sexual intercourse and vaginal stenosis.

The objective of this study will be to demonstrate the effectiveness of a treatment that will consist of a health education session related to the pelvic floor and the consequences related to cancer along with ten sessions of oncological perineal massage that will be carried out for fifty minutes, once a week.

Registry
clinicaltrials.gov
Start Date
May 31, 2024
End Date
December 20, 2025
Last Updated
yesterday
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
University of Alcala
Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. Daniel Pecos Martín

Professor

University of Alcala

Eligibility Criteria

Inclusion Criteria

  • Women between 18 and 52 years old
  • Oncology patients with a diagnosis of dyspareunia and vaginal stenosis related to treatments.
  • Patients with QT/RT/BT treatment who have a diagnosis of dyspareunia and vaginal stenosis.
  • Patients on hormonal suppressive treatment with a diagnosis of dyspareunia and vaginal stenosis.

Exclusion Criteria

  • Patients who do not accept intracavitary treatment.
  • Patients with abdominopelvic surgical treatment prior to oncological process.
  • Patients with a diagnosis of dyspareunia prior to cancer.
  • Patients with vaginal narrowing prior to cancer.
  • Patients with menopause at the time of cancer diagnosis

Arms & Interventions

Perineal massage

Ten sessions of perineal massage, which will be carried out for fifty minutes, once a week, together with a health education program.

Intervention: Perineal massage

Treatment with dilators

A health education session will be held but then the use of vaginal dilators will be done according to the gold standard treatment.

Intervention: Standard treatment

Outcomes

Primary Outcomes

Pain (Visual Analoge Scale)

Time Frame: Change from baseline at six months

Visual Analogical Scale (VAS) is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions. VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured orientated from the left "0" (worst) to the right "10"(best)

Secondary Outcomes

  • Female sexual function index(Change from baseline at six months)
  • Criteria for Adverse Events (CTCAE)(Change from baseline at six months)
  • Quality of life (EORCT QLQ-C30)(Change from baseline at six months)
  • Likert questionnaire by sexual dysfunction(Change from baseline at six months)

Study Sites (2)

Loading locations...

Similar Trials